Peer-reviewed economic analysis finds a combined ESR + CRP testing strategy reduces misdiagnoses and delivers net cost savings compared to CRP alone The $9.95 Million Question: Is ESR Worth Keeping? A ...
ALCOR Scientific reports a study indicating that combining ESR and CRP tests may reduce misdiagnoses and save hospitals ...
The erythrocyte sedimentation rate (ESR) remains a widely used clinical assay to assess systemic inflammation by measuring the rate at which erythrocytes settle in anticoagulated blood over a fixed ...
C-met as a therapeutic target using ARQ 197 in renal cell carcinoma. Background: Systemic inflammation has been associated with increased tumor grade and disease progression in renal cell carcinoma ...